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The U.S. Environmental Protection Agency 
(EPA) currently regulates particulate matter 
(PM) on the basis of mass in two size ranges: 
coarse PM [2.5–10 µm in aerodynamic 
diameter (PM2.5-10)] and fine PM (PM2.5). 
Coarse PM typically derives from soil or abra-
sive mechanical processes in transportation 
or industry, and also can contain biogenic 
materials such as pollen, endotoxin, and 
mold spores known to have deleterious effects 
on human health, especially in those with 
pulmonary diseases such as asthma. In the 
western United States, coarse PM typically 
comprises > 50% of measured PM10 mass 
on an annual basis, and approaches 70% in 
some areas of the Southwest. Fine PM derives 
primarily from combustion processes and 
may contain both primary particles directly 
emitted from specific sources and secondary 
particles formed by atmospheric chemistry 
changes over time. Wilson and Suh (1997) 
provide a detailed description of the occur-
rence and composition of coarse and fine PM 
and conclude that they are separate classes of 
pollutants and should be measured separately 
in epidemiology and toxicology studies.
In addition to difference in chemical 
composition, these two size fractions deposit 
in different locations in the lung, with coarse 
PM predominantly depositing in the more 
proximal portion of the lung (Kim and Hu 
1998). Because lung deposition and chemi-
cal composition of fine and coarse PM are 
generally dissimilar, PM may produce bio-
logic activity and health effects distinct in 
nature and severity from those effects seen 
with exposure to fine PM.
Epidemiology studies using time-series 
analyses have demonstrated significant cor-
relations between exposure to ambient PM 
air pollution and increased mortality and 
morbidity. Although most time-series studies 
have demonstrated health effects to be more 
strongly correlated with the PM2.5 fraction 
than with the PM2.5–10 fraction (Cifuentes 
et al. 2000; Klemm et al. 2000; Lipfert et al. 
2000; Schwartz and Neas 2000), there is 
some evidence for effects of coarse PM on 
mortality and morbidity, especially in arid 
regions where coarse PM concentrations are 
relatively high (Castillejos et al. 2000; Mar 
et al. 2000; Ostro et al. 2000). Epidemiologic 
evidence of health effects associated with 
coarse PM was recently reviewed (Brunekreef 
and Forsberg 2005).
A panel study of 19 nonsmoking older 
adults with cardiovascular disease residing in 
the Coachella Valley, California, reported an 
association between decreased heart rate vari-
ability (HRV) and coarse PM (Lipsett et al. 
2006). A panel study of 12 adult asthmat-
ics residing in Chapel Hill, North Carolina, 
reported associations between HRV, blood 
lipids, and circulating eosinophils and coarse, 
but not fine, PM (Yeatts et al. 2007).
Recently, virtual impactor technology 
(Demokritou et al. 2002; Kim et al. 2000) 
has been used to expose humans to concen-
trated fine ambient PM. These studies have 
reported that fine concentrated ambient 
particles (CAPs) can cause mild pulmonary 
inflammation and increased blood fibrino-
gen in healthy volunteers (Ghio et al. 2000, 
2003), decreased HRV in healthy elderly vol-
unteers (Devlin et al. 2002), decreased arterial 
oxygenation and HRV in elderly volunteers 
who are healthy but have chronic obstruc-
tive pulmonary disease (Gong et al. 2004a), 
and increased HRV and mediators of blood 
coagulation in healthy and asthmatic sub-
jects (Gong et al. 2003a). Additionally, expo-
sure of healthy volunteers to fine CAPs plus 
ozone caused brachial artery vasoconstriction 
(Brook et al. 2002) and increased diastolic 
blood pressure (Urch et al. 2005), and these 
findings were attributed primarily to CAP 
constituents (Urch et al. 2004).
To understand more fully the pathologic 
effects of the coarse fraction and to determine 
biological plausibility of epidemiologic stud-
ies, we examined the physiologic effects of 
concentrated Chapel Hill coarse CAPs on sev-
eral cardiac, blood, and pulmonary end points 
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Ba c k g r o u n d: There is ample epidemiologic and toxicologic evidence that exposure to fine particulate 
matter (PM) air pollution [aerodynamic diameter ≤ 2.5 µm (PM2.5)], which derives primarily from 
combustion processes, can result in increased mortality and morbidity. There is less certainty as to 
the contribution of coarse PM (PM2.5–10), which derives from crustal materials and from mechanical 
  processes, to mortality and morbidity. 
oB j e c t i v e: To determine whether coarse PM causes cardiopulmonary effects, we exposed 
14 healthy young volunteers to coarse concentrated ambient particles (CAPs) and filtered air. 
Coarse PM concentration averaged 89.0 µg/m3 (range, 23.7–159.6 µg/m3). Volunteers were 
exposed to coarse CAPs and filtered air for 2 hr while they underwent intermittent exercise in a 
single-blind, crossover study. We measured pulmonary, cardiac, and hematologic end points before 
exposure, immediately after exposure, and again 20 hr after exposure. 
re s u l t s: Compared with filtered air exposure, coarse CAP exposure produced a small increase in 
polymorphonuclear neutrophils in the bronchoalveolar lavage fluid 20 hr postexposure, indicating 
mild pulmonary inflammation. We observed no changes in pulmonary function. Blood tissue plas-
minogen activator, which is involved in fibrinolysis, was decreased 20 hr after exposure. The stan-
dard deviation of normal-to-normal intervals (SDNN), a measure of overall heart rate variability, 
also decreased 20 hr after exposure to CAPs. 
co n c l u s i o n s: Coarse CAP exposure produces a mild physiologic response in healthy young vol-
unteers approximately 20 hr postexposure. These changes are similar in scope and magnitude to 
changes we and others have previously reported for volunteers exposed to fine CAPs, suggesting that 
both size fractions are comparable at inducing cardiopulmonary changes in acute exposure settings.
key w o r d s : cardiovascular effects, coarse PM human study. Environ Health Perspect 117:1089–1094 
(2009).  doi:10.1289/ehp0900558 available via http://dx.doi.org/ [Online 23 March 2009]Graff et al.
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in young, healthy volunteers. This study is 
part of a continuing series of studies in which 
humans are exposed to different size fractions 
of Chapel Hill PM and will also allow us to 
compare the relative toxicity of coarse and 
fine PM from the same geographic location. 
We presented a brief comparison of humans 
exposed to three size fractions of Chapel Hill 
CAPs in condensed form in a symposium 
proceedings (Samet et al. 2007).
Materials and Methods
Study population. This was a single-blind, 
crossover study approved by the Committee 
on the Protection of the Rights of Human 
Subjects of the University of North Carolina at 
Chapel Hill School of Medicine. Before inclu-
sion, participants were informed of the study 
procedures and risks, signed a statement of 
informed consent and were approved for par-
ticipation by a U.S. EPA physician. Screening 
procedures included medical history, physical 
exam, and routine hematologic and biochemi-
cal tests. Specific exclusion criteria included any 
chronic medical condition or chronic medica-
tion use (except birth control pills, low-dose 
antibiotics for acne, or dietary supplements), 
significant risk factors for cardiovascular disease 
(e.g., high cholesterol or uncontrolled blood 
pressure), and current smokers or those with 
a significant smoking history within 1 year of 
study participation. Subjects suffering from 
seasonal allergies were not studied within 6 
weeks of a symptomatic episode, and no sub-
ject was studied within 4 weeks of a respiratory 
tract infection. Individuals unable to discon-
tinue substances that could potentially alter 
their inflammatory response (e.g., antioxidants, 
nonsteroidal anti-inflammatory agents) for at 
least 6 days before exposure were not allowed 
to participate. A urine pregnancy test was per-
formed on all females during the screening 
process and before each exposure.
Exposure of subjects to coarse CAPs.
Ambient air was drawn into an inlet duct 
on the roof of the U.S. EPA human stud-
ies facility (~ 30 m above ground level) in 
Chapel Hill at 5,000 L/min and transferred 
downward into the building to a PM10 inlet 
of the concentrator. The size selective inlet 
and the virtual impactors used to concentrate 
particles are identical to those developed by 
Demokritou et al. (2002). The major outward 
flow was 4,500 L/min for the first impaction 
stage and 450 L/min for the second impac-
tion stage, giving a 50 L/min concentrated 
aerosol outflow. We diluted the concentrated 
aerosol with 150 L/min of room-temperature 
dilution air [relative humidity (RH) ~ 30%], 
which was added to provide enough airflow 
for the human subjects’ breathing require-
ments. The dilution air was passed through 
HEPA filters and charcoal to strip it of par-
ticles and gaseous air pollutants. We assessed 
PM concentrations in the chamber by gravi-
metric analysis of filters. We placed the filters 
immediately upstream of the inlet duct to 
the chamber, about 30 in from the subject’s 
mouth. We measured real-time concentra-
tions upstream of the concentrator and in the 
chamber using a Fisher Scientific DataRam 
4 monitor (Franklin, MA) and used these 
concentrations to calculate the concentra-
tion factor, which ranged from 4- to 10-fold. 
We measured particle size distributions with 
a 3321 APS instrument (TSI Inc., St Paul, 
MN). Because coarse PM is not evenly dis-
tributed in a chamber of this size, each sub-
ject was seated with their mouths about 12 in 
from the chamber inlet duct. Even at that 
close distance, the subjects inhaled only 67% 
of the particles measured at the filter inlet. 
Table 1 shows the actual dose of particles 
inhaled by each subject.
Exposures were conducted in a specially 
designed Plexiglas chamber at approximately 
20°C and 40% RH. Participants were ran-
domly exposed to filtered air and concentrated 
PM2.5–10 for 120 min, with intermittent exer-
cise, on two separate occasions separated by at 
least 1 month. The exercise schedule consisted 
of 15 min of rest followed by 15 min of exer-
cise on a recumbent bicycle, repeated four 
times over the 120-min exposure session, with 
a target ventilation of 20 L/min/m2 during 
exercise. During a training session, the work-
load needed for each subject to achieve the 
target minute ventilation was calculated. Most 
subjects achieved the target using a work load 
of 75 W; however, the tension on the exercise 
bike was adjusted according to each subject’s 
calculations.
End point measurements. Bronchoscopy 
with lavage. Subjects underwent bronchoscopy 
with lavage approximately 20 hr after the com-
pletion of each exposure, as described in detail 
in Huang et al. (2006). We quantified cell 
numbers by counting in a hemocytometer and 
assessed viability by exclusion of trypan blue 
dye. Viability exceeded 90% in all samples. 
Cells were stained using DiffQuik reagents 
purchased from Sigma (St. Louis, MO), and 
we determined differential cell counts [poly-
morphonuclear neutrophils (PMNs), mac-
rophages, lymphocytes, monocytes, epithelial 
cells, and eosinophils] by counting at least 
300 cells under an oil-emersion lens. We 
stored bronchial lavage (BL) and broncho-
alveolar lavage (BAL) fluid at –80°C, and at 
the end of the study we used commercially 
available kits to quantify levels of interleukin 
(IL)-6 and IL-8 (R&D Systems, Minneapolis, 
MN), prostaglandin E2 (PGE2; New England 
Nuclear, Boston, MA), α1-antitrypsin 
(ALPCO Diagnostics, Windham, NH), and 
total protein (BioRad, Hercules, CA).
Spirometry. We assessed pulmonary 
function with a SensorMedics Vmax system 
(VIASYS, Conshohocken, PA). We took 
measurements of forced vital capacity (FVC), 
forced expiratory volume in 1 sec (FEV1), and 
carbon monoxide diffusion capacity (DLCO) 
before, after, and approximately 20 hr after 
the completion of each exposure as described 
earlier (Ghio et al. 2000).
Cellular and soluble blood components. 
We collected venous blood immediately 
before and approximately 1 hr and 20 hr after 
the completion of each exposure. Basic blood 
chemistry, complete blood count with differ-
ential, and serum catecholamines were mea-
sured by LabCorp (Burlington, NC) on the 
day the blood was drawn. Plasma and serum 
was also frozen at –80°C for later analysis. 
We used commercially available ELISA kits to 
quantify levels of C-reactive protein (ALPCO 
Diagnostics, Windham, NH); D-dimer and 
von Willebrand’s factor (vWF; Diagnostica 
Stago, Parsippany, NY); factor VII, factor IX, 
prothrombin, tissue plasminogen activator 
Table 1. Basic demographic and PM concentration data.
  Minute  PM concentration  Calculated PM dose
  ventilation  (µg/m3)  (µg)a
Subject  Sex  Age (years)  (L/min)  Total  Coarse  Total  Coarse
1  Male  29  21.7  170.3  159.6  297  278
2  Male  21  23.1  73.4  60.3  136  112
3  Female  22  20.1  232.8  196.9  375  317
4  Male  23  18.4  168.9  136.9  250  203
5  Male  26  21.3  100.0  75.0  171  128
6  Female  23  12.2  106.3  85.8  104  84
7  Female  22  26.1  56.1  56.1  117  117
8  Male  34  17.0  127.3  102.8  174  141
9  Male  28  26.2  27.4  23.7  58  50
10  Female  22  26.0  115.4  85.4  241  178
11  Male  34  22.7  120.9  106.2  220  193
12  Female  24  27.4  98.0  88.8  216  196
13  Female  20  24.5  36.5  31.8  63  55
14  Male  20  17.4  38.3  36.1  54  51
Mean ± SD    24.9 ± 4.7  21.5 ± 4.3  105.1 ± 58.3  89.0 ± 49.5  176.7 ± 95.9  150.3 ± 82.5
aCalculated PM dose (µg) = (minute ventilation × 120 min)/1,000 L × PM concentration × 0.67 (the estimated proportion 
of the particles being delivered to the airway, calculated by comparing PM values at the inlet to the chamber and a few 
inches away from a subject’s mouth).  Health effects of coarse PM
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(tPA), plasminogen, fibrinogen, and protein 
C (Enzyme Research Laboratories, South 
Bend, IN); and plasminogen activator inhibi-
tor 1 (DakoCytomation, Carpenteria, CA).
Heart rate variability (HRV). We collected 
continuous ambulatory electrocardiograms 
(ECGs) for approximately 24 hr using a 3100A 
Zymed Holter System (Phillips, Andover, MA)
and processed them by standard Zymed algo-
rithms. We sampled the ECGs at 120 Hz and 
stored all data on flash cards before process-
ing. An electrocardiographic research nurse 
blinded to the particle exposure randomiza-
tion then edited the sequence of ECG com-
plexes to ensure proper labeling of each QRS 
complex. From the edited records, we assessed 
time domain [standard deviation of normal-
to-normal intervals (SDNN) and percentage 
of differences between adjacent normal-to-
normal intervals that are > 50 msec (PNN50)] 
and frequency domain [total, low-frequency 
(LF; 0.03–0.15 Hz), and high-frequency (HF; 
0.15–0.4 Hz) power] variables for the 5-min 
time periods immediately before exposure and 
approximately 1 hr and 20 hr after the comple-
tion of each exposure. We conducted mea-
surements while subjects reclined quietly in a 
dark room for 30 min, with the final 10 min 
being used for HRV analysis. In addition to 
the 5-min intervals, we also calculated SDNN 
and average SDNN for the entire 24-hr ambu-
latory monitoring period.
Statistical analysis. We assessed lung func-
tion, blood, and Holter measurements imme-
diately before, 1 hr after, and 20 hr after each 
exposure. We assessed BAL/BL measurements 
only 20 hr postexposure. For analysis, we 
subtracted preexposure values from 1 hr and 
20 hr postexposure values and compared the 
air exposure differences with the CAP expo-
sure differences for each person. Data in the 
figures are percent change in these differences 
per 10-mg/m3 increase in PM concentration in 
the exposure chamber. Because we took BAL 
measurements only 20 hr postexposure, we 
compared only those values during the statisti-
cal analysis. Concentration of coarse PM in the 
chamber is measured on a continuous scale and 
varies from subject to subject depending on the 
outdoor PM concentration that day. Table 
1 shows the inhaled and chamber concentra-
tions during the CAP exposure. PM concentra-
tions in the chamber during air exposures were 
low, but not zero. We used linear mixed effects 
models (R statistical software, version 2.3.1, 
lmer package) to test differences in response 
between the CAP and filtered air exposures. 
More specifically, we used a random intercept 
model to account for the subject-level vari-
ability and estimated the slope parameter that 
described an expected change in response as a 
function of PM concentration. We summarize 
the estimates of slope on the basis of a 10-mg/
m3 increase in PM concentration. We also 
report the mean and standard error associated 
with each end point. We used an α of 0.05 to 
determine statistical significance.
Results
Study population and exposure. Table 1 con-
tains basic demographic PM concentration 
information. This study enrolled six female 
and eight male participants with a mean age 
of 24.9 years. All exposures began within 
30 min of 0945 hours to control for diurnal 
variations in physiologic response. Although 
we constructed the concentrator to concen-
trate only PM2.5–10, there is some concen-
tration of PM1–2.5 (particles between 1 and 
2.5 µm). “Total PM” in Table 1 refers to the 
combination of all particles present in the 
chamber. We observed substantial variation 
in concentrated PM exposure reflecting the 
natural daily variation in PM concentration 
outside the facility. CAP exposures took place 
from June to December, and, as expected, 
coarse PM concentrations were higher in the 
warmer months (Figure 1).
Coarse PM caused small but significant 
changes in lung neutrophils and monocytes. 
Total cell recoveries in the BL and BAL fluids 
did not differ between air- and CAP-exposed 
individuals. Figure 2 provides data for the cell 
differential end points. In the BAL fraction 
we observed a statistically significant 10.7% 
increase in percent PMNs per 10 µg/m3 of 
coarse PM (p = 0.0065), indicative of mild 
pulmonary inflammation. BAL PMN values 
in air-exposed individuals were 1.0 ± 0.30%. 
In the BL fraction, we observed a trend toward 
an increase in PMNs with increasing CAP 
concentration, although the trend was not sta-
tistically significant. We observed a small, but 
statistically significant, 2.0% decrease in per-
cent monocytes in the BL fraction (p = 0.05) 
per 10 µg/m3 of coarse PM. Monocyte levels 
in air-exposed individuals were 7.2 ± 0.8%. 
We observed no significant changes in any of 
the other cell types in either fraction.
Coarse PM caused a decrease in total 
protein in the BAL. We observed no differ-
ences in recovery of BL or BAL fluid between 
air- and CAP-exposed individuals. The group 
average return was within 10%, so soluble 
components were expressed per milliliter of 
lavage fluid. As shown in Figure 3, soluble 
markers of inflammation present in BAL 
and BL fluids (IL-6, IL-8, PGE2) were not 
changed after exposure to coarse CAPs for 
2 hr. However, we observed a 1.8% decrease 
in total protein in BAL fluid (p = 0.0191) per 
10 µg/m3 of coarse PM. Protein levels in BAL 
fluid of air-exposed individuals were 74.2 ± 
9.0 µg/mL. In an earlier study (Ghio et al. 
2000), we also reported decreased protein in 
lavage fluid of humans exposed to fine CAPs.
Coarse PM caused no changes in pulmonary 
function. We took lung function measurements 
before, immediately after, and again 20 hr after 
exposure to air and coarse CAPs. Relative to 
measurements taken before exposure, FEV1 
and FVC did not show statistically significant 
changes either immediately or 20 hr after expo-
sure to coarse CAPs (Figure 4). A recent study 
Figure 1. Correlation between coarse PM concentra-
tion in the exposure chamber and date of PM expo-
sure. The solid line represents the linear regression 
line. The correlation of determination (r2) is 0.55 
(p = 0.0025).
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Figure 2. Changes in the percentage of each cell 
type in the BL and BAL fluids. Most participants 
had zero basophils and eosinophils in either frac-
tion (data not shown).
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Figure 3. Changes in inflammatory mediators in the 
BL and BAL fluids. A1AT, α1-antitrypsin.
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reported changes in pulmonary diffusing capac-
ity (DLCO) for carbon monoxide in humans 
exposed to ultrafine carbon black particles 
(Pietropaoli et al. 2004). However, in this study 
we saw no change in DLCO either immediately 
or 20 hr after CAP exposure.
Coarse CAPs cause small changes in vascu-
lar factors involved in coagulation. We meas-
ured a number of soluble factors involved in 
clotting and coagulation before, immediately 
after, and again 20 hr after exposure to air or 
coarse CAPs. Relative to measurements taken 
before exposure, only tPA showed a signifi-
cant change after CAP exposure (Figure 5). tPA 
concentration decreased 32.9% from the mean 
baseline level (p = 0.01) per 10-µg/m3 increase 
in CAP concentration when measured approxi-
mately 20 hr after exposure. Decreased tPA 
levels could potentially result in the formation 
of less plasmin, a compound that plays a key 
role in dissolving blood clots that may have 
formed in blood vessels. D-dimer concentration 
decreased 11.3% per 10 µg/m3 of coarse PM 
20 hr after exposure, but the decrease did not 
quite achieve statistical significance (p = 0.07). 
tPA and D-dimer concentrations in blood 
drawn before exposure were 6.5 ± 1.6 ng/mL 
and 349 ± 61 ng/mL, respectively.
Other blood biomarkers. We also exam-
ined markers of systemic inflammatory pro-
cesses, catecholamines, and lipids in the blood 
(data not shown). Coarse CAP exposure did 
not cause significant changes in C-reactive 
protein, catecholamines, triglycerides, or cho-
lesterol (total, very-low-density, low-density, 
and high-density lipoproteins).
HRV. In a previous study (Devlin et al. 
2003), we reported that elderly healthy 
people exposed to fine CAPs had changes in 
both time- and frequency-domain variables as 
measured by Holter recording. In this study, 
we applied a Holter monitor to each sub-
ject before exposure, which the subject wore 
for 24 hr. We measured SDNN, a marker 
of overall HRV, using data from the entire 
monitoring period. We measured PNN50, 
LF, HF, and total power during three 5-min 
periods when the subject was lying at rest: 
immediately before, immediately after, and 
20 hr after exposure to air or coarse CAPs. 
Relative to the measurements taken before 
exposure, SDNN decreased 14.4% from the 
mean baseline level per 10-µg/m3 increase in 
CAP concentration during a resting period 
20 hr postexposure (p = 0.05) (Figure 6). We 
observed no statistically significant changes 
in any of the other HRV end points at either 
postexposure measurement and no changes in 
the 24-hr end points measurements.
Discussion
The recent development of second-generation 
particle concentrators has made it possible to 
examine the effects of real-time exposure to 
atmospheres in which size-fractionated PM is 
selectively concentrated. This study shows that 
an acute exposure of healthy young adults to 
concentrated coarse CAPs resulted in signifi-
cant changes in indices of pulmonary inflam-
mation, hemostasis, and autonomic nervous 
system balance. The mean coarse PM concen-
tration (105.1 µg/m3) measured at the inlet 
to the exposure chamber in this study is not 
unrealistically high and can be found in many 
areas throughout the world, including loca-
tions in the U.S. Southwest. Furthermore, the 
actual PM concentration at the mouth of the 
subject was only 67% of that measured at the 
chamber inlet, resulting in average exposures 
to only 70.3 µg/m3. Table 1 shows the actual 
dose of PM inhaled by each person, taking 
ventilation into account. 
Coarse PM are preferentially deposited 
in the proximal region of the lung. They also 
contain the bulk of particle-bound biological 
material such as lipopolysaccharide, which is 
a known proinflammatory agent. Therefore, 
we expected that coarse CAP exposure would 
elicit an inflammatory response (PMN influx) 
in the lung. Indeed, we did find a small but 
statistically significant increase in the percent-
age of PMNs in the BAL fluid. In a previous 
study, we exposed young, healthy volunteers 
to fine CAPs (PM2.5), divided into four con-
centrations quartiles of 0 (filtered air), 47.2, 
107.4, and 206.7 µg/m3 (Ghio et al. 2000). In 
the present study, the mean PM concentration 
(105.1 µg/m3) was very close to the mean con-
centration of the third quartile in the fine CAP 
study (107.4 µg/m3) and resulted in an iden-
tical percentage of PMNs in the BAL fluid, 
suggesting that coarse and fine PM may be 
equally potent in inducing pulmonary inflam-
mation. Other studies have not reported an 
influx of inflammatory cells into the lung after 
exposure of humans to CAPs. However, those 
studies used induced sputum to obtain cells 
from the respiratory tract rather than BAL, 
and we have found the latter is a more sensi-
tive and less noisy method to measure lung 
inflammation, particularly when the percent 
influx of PMNs is small.
We did not observe decreases in lung func-
tion in this study, nor did we observe increases 
in soluble markers of pulmonary inflammation 
such as IL-6, IL-8, or PGE2. This is in agree-
ment with other studies in which both healthy 
humans and those with pulmonary disease 
have been exposed to CAPs (Ghio et al. 2000; 
Gong et al. 2003a, 2003b, 2004a, 2008) and 
strengthens the notion that acute exposure to 
air pollution particles generally does not seem 
to result in substantial changes to the respi-
ratory system. In contrast to CAP exposure, 
our previous studies in which humans were 
exposed to low levels of ozone have shown a 
marked decrease in pulmonary function and 
increase in inflammatory cells and cytokines 
(Devlin et al. 1991; Horstman et al. 1990), 
suggesting that particles and ozone exert their 
effects via dissimilar mechanisms.
In this study, we found decreased blood 
plasma tPA levels 20 hr after exposure to coarse 
CAPs. tPA is a protein that is involved in the 
breakdown of blood clots by catalyzing the 
conversion of plasminogen to plasmin, the 
major enzyme responsible for clot breakdown. 
Figure 4. Changes in measures of pulmonary func-
tion: immediately after exposure (Post) and approx-
imately 20 hr after exposure (Follow-up).
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Figure 5. Changes in mediators of coagulation: 
immediately after exposure (Post) and approxi-
mately 20 hr after exposure (Follow-up). PAI-1, 
plasminogen activator inhibitor-1. 
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Figure 6. Changes in resting HRV measurements: 
immediately after exposure (Post) and approxi-
mately 20 hr after exposure (Follow-up). 
SDNN
PNN50
Low frequency
High frequency
Total power
100 50 –50 –100 0 150
Percent change per 10-µg/m3 
increase in PM concentration
Post
Follow-up Health effects of coarse PM
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 7 | July 2009  1093
Decreased tPA levels could inhibit the break-
down of any clots formed by particles, thus 
increasing the odds of a thromboembo-
lic event. These findings add to the growing 
number of studies that have found associations 
between PM exposure and alterations in indi-
ces of hemostasis and thrombosis. We previ-
ously reported elevations in blood fibrinogen, a 
fibrin precursor and acute phase reactant, in the 
blood of healthy volunteers 24 hr after expo-
sure to fine CAPs (Ghio et al. 2003). Increased 
blood fibrinogen has also been associated with 
exposure to air pollution in a number of panel 
studies (Chuang et al. 2007; Liao et al. 2005; 
Pekkanen et al. 2000; Ruckerl et al. 2007). We 
also reported an association between PM and 
vWF, a glycoprotein involved in endothelial 
cell activation, hemostasis, and platelet adhe-
sion, in a panel of highway patrol troopers 
exposed to near-road air pollution (Riediker 
et al. 2004). Others have also reported asso-
ciations between PM exposure and increased 
vWF (Liao et al. 2005), as well as plasminogen 
activator inhibitor (Chuang et al. 2007; Mills 
et al. 2005; Su et al. 2006). Taken as a whole, 
these studies indicate that exposure to PM has 
the potential to alter hemostatic balance func-
tion in the blood, favoring a prothrombogenic 
environment and interfering with fibrinolytic 
pathways. Whether these changes in hemo-
static factors contribute to the triggering of car-
diovascular and other thrombotic events after 
PM exposure remains to be established.
Analysis of HRV is a noninvasive method 
to assess the function of the autonomic ner-
vous system. Reduced HRV is considered a 
prognostic marker for adverse cardiovascular 
events in patients with a prior myocardial 
infarction. Panel studies have consistently 
associated fine PM exposure with decreased 
HRV. Gold et al. (2000) reported an associa-
tion between decreased SDNN and increased 
PM2.5, as did Liao et al. (1999) and Pope 
et al. (1999). Previous work from our group 
demonstrated that healthy elderly individuals 
without overt cardiovascular disease exposed 
to fine CAPs experienced decreased SDNN 
and HF HRV in 5-min resting intervals 
immediately and 24 hr after exposure (Devlin 
et al. 2003). A similar study by Gong et al. 
(2004a) involving healthy elderly individuals 
exposed to fine CAPs reported a significant 
decrease in SDNN 18 hr after exposure.
In this study we extend our earlier find-
ings by showing that exposure to coarse CAPs 
also results in decreased SDNN 20 hr after 
exposure. These results are in agreement with 
an earlier study which also reported decreased 
SDNN in healthy volunteers exposed to coarse 
CAPs (Gong et al. 2004b). They are also in 
agreement with a recent panel study in which 
we reported an association between coarse PM 
and decreased SDNN in asthmatics (Yeatts 
et al. 2007).
A note of caution must be exercised in 
interpreting these findings. We measured 
multiple end points in the lung, blood, and 
heart. Therefore, some of the statistically sig-
nificant findings may have been due to chance 
alone. It will be important to see whether 
these findings can be replicated in our own 
and others’ studies.
There has been considerable discussion 
about the pathways by which PM can cause 
acute cardiovascular changes. One of the 
early thoughts was that particles could cause 
changes to the primary target organ, the lung, 
which would spill over into the vascular sys-
tem and secondarily affect autonomic func-
tion. However, data from numerous human 
and animal toxicology studies suggest that 
CAPs do not induce sufficient pulmonary 
responses to cause these kinds of second-
ary effects. Indeed, if this were the case, one 
might expect that ozone, a powerful inducer 
of pulmonary inflammation, would be able 
to cause even more substantial cardiovascular 
changes than PM, which has not been shown 
to date.
Recent studies in rodents have hypoth-
esized that ultrafine PM (PM0.1; those 
< 0.1 µm in diameter) may actually leave the 
lung and directly attack the cardiovascular sys-
tem (Nemmar et al. 2002; Oberdorster et al. 
2002). Although this mechanism may play a 
role in cardiovascular effects caused by ultra-
fine PM, the large size of coarse PM makes 
it unlikely that they can pass directly into the 
circulation. However, it does not exclude the 
possibility that soluble components of coarse 
PM may find their way into the circulatory 
system. Recent in vitro experiments in our 
laboratory have shown that 40% of the activ-
ity of coarse PM that affects cultured airway 
epithelial cells resides in the water-soluble 
portion of the PM (data not shown).
A third possibility is that PM, regardless 
of size, may affect the cardiovascular system 
through nerve impulses transmitted from 
the lung to the brain. Ozone-induced dec-
rements in lung function are thought to be 
mediated via interaction of the pollutant with 
C-fibers innervating the lung in humans and 
dogs (Bromberg and Koren 1995; Coleridge 
et al. 1993; Passannante et al. 1998). 
Administration of β-adrenergic receptor and 
muscarinic receptor antagonists effectively 
blocked PM-induced cardiac oxidative stress 
in rats (Rhoden et al. 2005). Capsazepine, 
a selective antagonist of the vanilloid recep-
tor present on pulmonary C-fibers, blunt 
PM-induced changes in cardiac oxidative 
stress and edema in rats (Ghelfi et al. 2008). 
Tunnicliffe et al. (2001) reported HRV 
changes but no respiratory system changes in 
humans exposed to sulfur dioxide, suggesting 
that a cardiac autonomic effect can be trig-
gered by upper-airway irritant receptors.
Conclusions
The results of this study showed that young, 
healthy people experience mild acute physi-
ologic effects when exposed to environmentally 
relevant coarse air pollution PM. The results of 
this study are generally consistent with those 
of previously published studies examining the 
effects of both coarse and fine PM, suggesting 
that both particle size fractions are roughly 
equivalent in inducing cardiopulmonary 
changes in healthy humans. However, given 
the large number of end points typically mea-
sured in these studies, the relatively small num-
ber of positive findings makes it important for 
these findings to be replicated in future studies.
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